A Randomised Controlled Trial of Self-help Mindfulness-based Cognitive Therapy for Health Workers (MindSHINE2)

March 20, 2019 updated by: Canterbury Christ Church University

A Randomised Controlled Trial of a Mindfulness-based Cognitive Therapy Self-help Intervention for UK National Health Service Employees

This study examines whether a mindfulness-based self-help book is effective at reducing healthcare workers' levels of stress and improving their wellbeing.

Study Overview

Detailed Description

This study is a randomised controlled trial (RCT) examining the efficacy of a mindfulness-based cognitive therapy self-help book ('Mindfulness: A practice guide to finding peace in a frantic world') relative to a wait-list control, in healthcare staff. It builds on a previous pilot RCT (http://www.isrctn.com/ISRCTN16486066). A battery of measures will be administered at baseline (week 0), post-intervention (week 9) and follow-up (week 21). This trial is designed to test the following hypotheses.

Primary Hypothesis

-Mindfulness-based cognitive therapy self-help (MBCT-SH) participants, in comparison to waitlist control participants, will show a reduction in symptoms of stress by the end of MBCT-SH (week 9).

Secondary Hypotheses

  • The improvement detailed in the primary hypothesis will be maintained at a follow-up 12 weeks after the end of the MBCT-SH (week 21).
  • MBCT-SH participants, in comparison to waitlist control participants, will show improvements in mindfulness, other-compassion, self-compassion, anxiety, depression, burnout and mental well-being by the end of MBCT-SH (week 9), and these improvements will be maintained at a follow-up 12 weeks after the end of the MBCT-SH (week 21).
  • MBCT-SH participants, in comparison to waitlist control participants, will show a reduction in the number of sickness absence days from the three months preceding the intervention to the three months following the intervention.
  • Increases in self-compassion and mindfulness from week 0 to week 9, will mediate the effects of MBCT-SH (relative to waitlist control) on levels of stress, depression, anxiety, wellbeing and burnout.

Study Type

Interventional

Enrollment (Actual)

102

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Kent
      • Dartford, Kent, United Kingdom, DA2 7WG
        • Oxleas NHS foundation trust
    • Sussex
      • Hove, Sussex, United Kingdom, BN3 7HZ
        • Sussex Partnership NHS Foundation Trust

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Being currently employed by Sussex Partnership NHS Foundation Trust (in the UK) in a role or roles that involve direct delivery of healthcare.
  2. Having at least one day per week of direct contact with UK National Health Service service users.
  3. Agreeing to refrain from engaging in another form of psychological therapy during the course of the study.
  4. Having self-reported sufficient English language reading ability to read and understand the self-help book

Exclusion Criteria:

  1. Being currently on leave of absence from work.
  2. Having previously received a minimum dose (defined as 50% of a course or more) of a mindfulness-based intervention.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: MBCT-SH
MBCT-SH will be an unguided, mindfulness-based cognitive therapy, book-based self-help intervention.
Participants will be provided with a copy of the self-help book, and asked to read it and follow the activities outlined in it, over eight weeks. They will receive weekly standardized emails, to provide information about mindfulness and encouragement to engage with the self-help book.
No Intervention: Control
A wait list control group who will receive no intervention during the 21 weeks of the study. Control participants will be provided with the self-help book that the MBCT-SH group received after week 21.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Stress
Time Frame: Post-intervention (i.e. 9-weeks after baseline)
Change from baseline at 9-weeks on the Stress sub-scale of the Depression, Anxiety and Stress Scale-21
Post-intervention (i.e. 9-weeks after baseline)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Stress (follow-up)
Time Frame: Follow-up (i.e. 21 weeks after baseline)
Change from baseline at 21-weeks on the Stress sub-scale of the Depression, Anxiety and Stress Scale-21
Follow-up (i.e. 21 weeks after baseline)
Depression
Time Frame: Post-intervention (i.e. 9-weeks after baseline)
Change from baseline at 9-weeks on the Depression sub-scale of the Depression, Anxiety and Stress Scale-21
Post-intervention (i.e. 9-weeks after baseline)
Depression (follow-up)
Time Frame: Follow-up (i.e. 21 weeks after baseline)
Change from baseline at 21-weeks on the Depression sub-scale of the Depression, Anxiety and Stress Scale-21
Follow-up (i.e. 21 weeks after baseline)
Anxiety
Time Frame: Post-intervention (i.e. 9-weeks after baseline)
Change from baseline at 9-weeks on the Anxiety sub-scale of the Depression, Anxiety and Stress Scale-21
Post-intervention (i.e. 9-weeks after baseline)
Anxiety (follow-up)
Time Frame: Follow-up (i.e. 21 weeks after baseline)
Change from baseline at 21-weeks on the Anxiety sub-scale of the Depression, Anxiety and Stress Scale-21
Follow-up (i.e. 21 weeks after baseline)
Compassion for others
Time Frame: Post-intervention (i.e. 9-weeks after baseline)
Change from baseline at 9-weeks on the Compassion Scale
Post-intervention (i.e. 9-weeks after baseline)
Compassion for others (follow-up)
Time Frame: Follow-up (i.e. 21 weeks after baseline)
Change from baseline at 21-weeks on the Compassion Scale
Follow-up (i.e. 21 weeks after baseline)
Self-compassion
Time Frame: Post-intervention (i.e. 9-weeks after baseline)
Change from baseline at 9-weeks on the Self-compassion Scale - Short Form
Post-intervention (i.e. 9-weeks after baseline)
Self-compassion (follow-up)
Time Frame: Follow-up (i.e. 21 weeks after baseline)
Change from baseline at 21-weeks on the Self-compassion Scale - Short Form
Follow-up (i.e. 21 weeks after baseline)
Mindfulness
Time Frame: Post-intervention (i.e. 9-weeks after baseline)
Change from baseline at 9-weeks on the Five-Facet Mindfulness Questionnaire - Short Form
Post-intervention (i.e. 9-weeks after baseline)
Mindfulness (follow-up)
Time Frame: Follow-up (i.e. 21 weeks after baseline)
Change from baseline at 21-weeks on the Five-Facet Mindfulness Questionnaire - Short Form
Follow-up (i.e. 21 weeks after baseline)
Burnout
Time Frame: Post-intervention (i.e. 9-weeks after baseline)
Change from baseline at 9-weeks on the Maslach Burnout Inventory
Post-intervention (i.e. 9-weeks after baseline)
Burnout (follow-up)
Time Frame: Follow-up (i.e. 21 weeks after baseline)
Change from baseline at 21-weeks on the Maslach Burnout Inventory
Follow-up (i.e. 21 weeks after baseline)
Mental Wellbeing
Time Frame: Post-intervention (i.e. 9-weeks after baseline)
Change from baseline at 9-weeks on the Short Warwick-Edinburgh Mental Well-being Scale
Post-intervention (i.e. 9-weeks after baseline)
Mental Wellbeing (follow-up)
Time Frame: Follow-up (i.e. 21 weeks after baseline)
Change from baseline at 21-weeks on the Short Warwick-Edinburgh Mental Well-being Scale
Follow-up (i.e. 21 weeks after baseline)
Sickness absence
Time Frame: Follow-up (i.e. 21 weeks after baseline)
Change from baseline in the number of days of sickness absence over the previous 12 weeks at 21 weeks.
Follow-up (i.e. 21 weeks after baseline)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Emily C Ironmonger, MSc, Canterbury Christ Church University
  • Study Director: Clara Strauss, PhD, Sussex Partnership NHS Foundation Trust & University of Sussex
  • Study Director: Kate Cavanagh, PhD, University of Sussex
  • Study Director: Fergal Jones, PhD, Canterbury Christ Church University & Sussex Partnership NHS Foundation Trust

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 26, 2017

Primary Completion (Actual)

June 22, 2018

Study Completion (Actual)

June 22, 2018

Study Registration Dates

First Submitted

January 20, 2017

First Submitted That Met QC Criteria

January 20, 2017

First Posted (Estimate)

January 24, 2017

Study Record Updates

Last Update Posted (Actual)

March 22, 2019

Last Update Submitted That Met QC Criteria

March 20, 2019

Last Verified

March 1, 2019

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • EmilyIronmongerMRP2016
  • IRAS ID: 215054 (Other Identifier: UK National Health Service Health Research Authority)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Psychological Stress

3
Subscribe